To verify these observations at the protein level, we determined FoxM1 expression using a tissue microarray (TMA) constructed in our laboratory, which harbors 13 astrocytomas (grade II), 25 anaplastic astrocytomas (grade III) and 80 GBM (grade IV) specimens. This evidence concerns the gene FOXM1 and glioblastoma.